Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients

Licia Grazzi, Eleonora Grignani, Domenico D’Amico, Emanuela Sansone, Alberto Raggi

Research output: Contribution to journalReview article

Abstract

Purpose of Review: The aim is twofold. First, to give an insight on the role exerted by different classes of drugs in favouring migraine chronification. Second, to explore the relationship between type and amount of overused medications and history of previous withdrawal treatment and of frequent relapses. Recent Findings: All drug classes were found to favour migraine chronification. No data are available for the association with relapses into CM-MOH. Our clinical study shows that patients who underwent previous withdrawal treatments were more likely to be overusers of multiple drug classes and overuse higher amounts of symptomatic medications, particularly, indomethacin, eletriptan and tramadol. Frequent relapsers were more likely to be overusers of opioids or ergotamine and caffeine derivates or of multiple classes, particularly acetylsalicylic acid and ergotamine/caffeine derivates. Summary: The joint results our review and clinical study do not seem to support the idea that MOH is drug-specific: rather, it points out that all drug classes may induce migraine chronification. Those drugs which are at higher risk of overuse are among those preferred by the “worst” patients, i.e. those who needed one or more withdrawal treatments for MOH. Our results reinforce the clinical impression that patients with CM and MOH, and particularly the most difficult to treat for their poor response to withdrawal treatments, are characterised by a particular drive towards the consumption of “whatever is likely to be perceived to provide some relief”, despite these drugs that are perceived as “more powerful”, are often indicated as second- or third-line medications.

Original languageEnglish
Article number71
JournalCurrent Pain and Headache Reports
Volume22
Issue number11
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Pharmaceutical Preparations
Migraine Disorders
Recurrence
Tramadol
Therapeutics
Prescription Drug Overuse
Indomethacin
Opioid Analgesics
Aspirin
Joints
ergotamine drug combination caffeine
Clinical Studies

Keywords

  • Anti-inflammatory drugs
  • Chronic migraine
  • Medication-overuse headache
  • Opioids
  • Triptans
  • Withdrawal

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients. / Grazzi, Licia; Grignani, Eleonora; D’Amico, Domenico; Sansone, Emanuela; Raggi, Alberto.

In: Current Pain and Headache Reports, Vol. 22, No. 11, 71, 01.11.2018.

Research output: Contribution to journalReview article

@article{3cf1d8cc4f8644feaff44045b524b141,
title = "Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients",
abstract = "Purpose of Review: The aim is twofold. First, to give an insight on the role exerted by different classes of drugs in favouring migraine chronification. Second, to explore the relationship between type and amount of overused medications and history of previous withdrawal treatment and of frequent relapses. Recent Findings: All drug classes were found to favour migraine chronification. No data are available for the association with relapses into CM-MOH. Our clinical study shows that patients who underwent previous withdrawal treatments were more likely to be overusers of multiple drug classes and overuse higher amounts of symptomatic medications, particularly, indomethacin, eletriptan and tramadol. Frequent relapsers were more likely to be overusers of opioids or ergotamine and caffeine derivates or of multiple classes, particularly acetylsalicylic acid and ergotamine/caffeine derivates. Summary: The joint results our review and clinical study do not seem to support the idea that MOH is drug-specific: rather, it points out that all drug classes may induce migraine chronification. Those drugs which are at higher risk of overuse are among those preferred by the “worst” patients, i.e. those who needed one or more withdrawal treatments for MOH. Our results reinforce the clinical impression that patients with CM and MOH, and particularly the most difficult to treat for their poor response to withdrawal treatments, are characterised by a particular drive towards the consumption of “whatever is likely to be perceived to provide some relief”, despite these drugs that are perceived as “more powerful”, are often indicated as second- or third-line medications.",
keywords = "Anti-inflammatory drugs, Chronic migraine, Medication-overuse headache, Opioids, Triptans, Withdrawal",
author = "Licia Grazzi and Eleonora Grignani and Domenico D’Amico and Emanuela Sansone and Alberto Raggi",
year = "2018",
month = "11",
day = "1",
doi = "10.1007/s11916-018-0729-x",
language = "English",
volume = "22",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Current Science, Inc.",
number = "11",

}

TY - JOUR

T1 - Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients

AU - Grazzi, Licia

AU - Grignani, Eleonora

AU - D’Amico, Domenico

AU - Sansone, Emanuela

AU - Raggi, Alberto

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Purpose of Review: The aim is twofold. First, to give an insight on the role exerted by different classes of drugs in favouring migraine chronification. Second, to explore the relationship between type and amount of overused medications and history of previous withdrawal treatment and of frequent relapses. Recent Findings: All drug classes were found to favour migraine chronification. No data are available for the association with relapses into CM-MOH. Our clinical study shows that patients who underwent previous withdrawal treatments were more likely to be overusers of multiple drug classes and overuse higher amounts of symptomatic medications, particularly, indomethacin, eletriptan and tramadol. Frequent relapsers were more likely to be overusers of opioids or ergotamine and caffeine derivates or of multiple classes, particularly acetylsalicylic acid and ergotamine/caffeine derivates. Summary: The joint results our review and clinical study do not seem to support the idea that MOH is drug-specific: rather, it points out that all drug classes may induce migraine chronification. Those drugs which are at higher risk of overuse are among those preferred by the “worst” patients, i.e. those who needed one or more withdrawal treatments for MOH. Our results reinforce the clinical impression that patients with CM and MOH, and particularly the most difficult to treat for their poor response to withdrawal treatments, are characterised by a particular drive towards the consumption of “whatever is likely to be perceived to provide some relief”, despite these drugs that are perceived as “more powerful”, are often indicated as second- or third-line medications.

AB - Purpose of Review: The aim is twofold. First, to give an insight on the role exerted by different classes of drugs in favouring migraine chronification. Second, to explore the relationship between type and amount of overused medications and history of previous withdrawal treatment and of frequent relapses. Recent Findings: All drug classes were found to favour migraine chronification. No data are available for the association with relapses into CM-MOH. Our clinical study shows that patients who underwent previous withdrawal treatments were more likely to be overusers of multiple drug classes and overuse higher amounts of symptomatic medications, particularly, indomethacin, eletriptan and tramadol. Frequent relapsers were more likely to be overusers of opioids or ergotamine and caffeine derivates or of multiple classes, particularly acetylsalicylic acid and ergotamine/caffeine derivates. Summary: The joint results our review and clinical study do not seem to support the idea that MOH is drug-specific: rather, it points out that all drug classes may induce migraine chronification. Those drugs which are at higher risk of overuse are among those preferred by the “worst” patients, i.e. those who needed one or more withdrawal treatments for MOH. Our results reinforce the clinical impression that patients with CM and MOH, and particularly the most difficult to treat for their poor response to withdrawal treatments, are characterised by a particular drive towards the consumption of “whatever is likely to be perceived to provide some relief”, despite these drugs that are perceived as “more powerful”, are often indicated as second- or third-line medications.

KW - Anti-inflammatory drugs

KW - Chronic migraine

KW - Medication-overuse headache

KW - Opioids

KW - Triptans

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=85052295061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052295061&partnerID=8YFLogxK

U2 - 10.1007/s11916-018-0729-x

DO - 10.1007/s11916-018-0729-x

M3 - Review article

C2 - 30151604

AN - SCOPUS:85052295061

VL - 22

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 11

M1 - 71

ER -